Altered serum levels of insulin-like growth-factor binding proteins in breast cancer patients

Annals of Surgical Oncology

Volumn 5, Issue 2, 1998, Pages 194-201

  Ng, Eng Hen ^a   Ji, Chen Yang ^b   Tan, Puay Hoon ^b   Lin, Valerie ^b   Soo, Khee Chee ^b   Lee, Kok Onn ^b  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

^b NONE

Author keywords

Breast cancer; Insulin like growth factor binding proteins

Indexed keywords

SOMATOMEDIN BINDING PROTEIN;

ADULT; AGED; ARTICLE; BREAST CARCINOGENESIS; BREAST CARCINOMA; CANCER RISK; DIAGNOSTIC VALUE; DISEASE MARKER; FAMILY HISTORY; FEMALE; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; ORAL CONTRACEPTION; PARITY; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; RISK ASSESSMENT;

AGE FACTORS; AGED; BIOLOGICAL AVAILABILITY; BIOPSY; BLOTTING, WESTERN; BODY MASS INDEX; BREAST NEOPLASMS; CARCINOGENS; CARCINOMA; CASE-CONTROL STUDIES; CONFOUNDING FACTORS (EPIDEMIOLOGY); CONTRACEPTIVES, ORAL; DISEASE SUSCEPTIBILITY; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 4; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; LOGISTIC MODELS; MENARCHE; MENOPAUSE; MIDDLE AGED; MITOGENS; MULTIVARIATE ANALYSIS; ODDS RATIO; PARITY; RECEPTORS, PROGESTERONE; RISK FACTORS; TUMOR CELLS, CULTURED;

EID: 0032435114     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02303854     Document Type: Article

References (31)

1. Huff KK, Kaufman D, Gabbay KH, Spencer EM, Lippman ME, Dickson RB. Secretion of an insulin-growth like factor I related protein by human breast cancer cells. Cancer Res 1986;46:4613-9.
2. Karey KP, Sirbasku DA. Differential responsiveness and human breast cancer cell lines MCF-7 and T47D to growth factors and 17B estradiol. Cancer Res 1988;48:4083-92.
3. Peyrat JP, Bonneterre J. Type I IGF receptor in human breast diseases. Breast Cancer Res Treat 1992;22:59-67.
4. Artega CL, Osborne CK. Growth inhibition of human breast cancer cells in vitro with an antibody against the type 1 somatomedin receptor. Cancer Res 1989;49:6237-41.
5. Blum WF, Jenne EW, Reppin F, Kietzmann K, Ranke MB, Bierich JR. Insulin-like growth factor I (IGF-1) binding protein complex is a better mitogen than free IGF-1. Endocrinology 1989;125:766-72.
6. De Mellow JSM, Baxter RC. Growth hormone dependent insulin-like growth (IGF) binding protein inhibits and potentiates IGF-1 stimulated DNA synthesis in human skin fibroblasts. Biochem Biophys Res Commun 1988;156:199-204.
7. Clemmons DR, Elgin RG, Han VGM. Cultured fibroblast monolayers secrete a protein that alters the cellular binding of somatomedin C/insulin-like growth factor 1. J Clin Invest 1986;77:1548-56.
8. Suikkari AM, Koivisto VA, Rutanen EM, Yki-Jarvinen H, Karonen SL, Seppala M. Insulin regulates the serum levels of low molecular weight insulin-like growth factor binding protein. J Clin Endocrinol Metab 1988;66:266-72.
9. Busby WH, Snyder DK, Clemmons DR. Radioimmunoassay of a 26,000-dalton plasma insulin-like growth factor binding protein: control by nutritional variables. J Clin Endocrinol Metab 1988;67: 1225-30.
10. Cotterill AM, Holly JMP, Wass JAH. The regulation of insulin-like growth factor binding protein (IGFBP)-1 during prolonged fasting. Clin Endocrinol 1993;39:357-62.
11. Clemmons DR, Snyder DK, Busby WH Jr. Variables controlling the secretion of insulin-like growth factor binding protein-2 in normal human subjects. J Clin Endocrinol Metab 1991;73:727-33.
12. Brier BH, Gallaher BW, Gluckman PD. RIA for IGF-1: solutions to some potential problems and pitfalls. J Endocrinol 1991;128: 347-57.
13. Lee KO, Ng SC, Lee PS, Bongso AT, Taylor EA, Lin TK, Ratnam SS. The effect of growth hormone therapy on men with severe idiopathic oligozoospermia. Eur J Endocrinol 1995;132:159-63.
14. Hossenlopp P, Seurin D, Segovia-Quinson B, Hardouin S, Binoux M. Analysis of serum insulin-like growth factor binding proteins using Western blotting; using the method for titration of binding proteins and competitive binding studies. Ann Biochem 1986;154: 138-43.
15. Lee KO, Oh Y, Giudice LC, Cohen P, Peehl DM, Rosenfeld RG. Identification of insulin-like growth factor binding protein (IG-FBP)-3 fragments, and IGFBP-5 proteolytic activity in human seminal plasma: a comparison of normal and vasectomized patients. J Clin Endocrinol Metab 1994;79:1367-72.
16. Wang HS, Lee JD, Soong YK. Serum levels of serum insulin-like growth factor 1 and serum insulin-like growth factor-binding proteins -1 and -3 in women with regular menstrual cycles. Fertil Steril 1995;63:1204-9.
17. Clemmons DR, Underwood LE, Dickerson RN, Brown RO, Hak LJ, MacPhee RD, Heizer WD. Use of plasma somatomedin-C/ serum insulin-like growth factor 1 measurements to monitor the response to nutritional repletion in malnourished patients. Am J Clin Nutr 1985;41:191-8.
18. Unterman TG, Vazquez RM, Slas AJ, Martyn PA, Phillips LS. Nutrition and somatomedin XIII. Usefulness of somatomedin-C in nutritional assessment. Am J Med 1985;78:228-34.
19. Favoni RE, de Cupis A, Perotta A, Sforzini S, Amoroso D, Pensa F. Miglietta L. Insulin-like growth factor 1 (IGF-1) and IGF-binding proteins blood serum levels in women with early and late stage breast cancer; mutual relationship and possible correlation with patients hormone status. J Cancer Res Clin Oncol 1995;121: 674-82.
20. Bruning PF, Van Doorn J, Bonfrer JMG, Van Noord PAH, Korse CM, Linders TC, Hart AAM. Insulin-like growth factor binding protein 3 is decreased in early operable pre-menopausal breast cancer. Int J Cancer 1995;62:266-70.
21. Purohit A, Chapman O, Duncan L, Reed MJ. Modulation of oestrone sulphatase activity in breast cancer cell lines by growth factors. J Steroid Biochem Mol Biol 1992;41:563-66.
22. Lueprasitsakul P, Latour D, Longcope C. Aromatase activity in human adipose-tissue: stromal effects of growth factors. Steroids 1990;55:540-4.
23. Colletti RB, Roberts JD, Devlin JT, Copeland KC. Effects of tamoxifen on plasma insulin-like growth factor 1 in patients with breast cancer. Cancer Res 1989;49:1882-4.
24. Pratt SE, Pollak MN. Estrogen and antiestrogen modulation of MCF7 human breast cancer cell proliferation is associated with specific alterations in accumulation of insulin-like growth factor-binding proteins in conditioned media. Cancer Res 1993;53: 5193-8.
25. Adamo ML, Shao Z, Lanau F, et al. Insulin-like growth factor 1 and retinoic acid modulation of IGF-binding proteins:IGFBP-2,-3,-4 gene expression and protein secretion in a breast cancer cell line. Endocrinology 1992;131:1858-66.
26. Oh Y, Mullers HL, Ng L, Rosenfeld RG. Transforming growth factor-b-induced cell growth inhibition in human breast cancer cells is mediated through insulin-like growth factor-binding protein-3 action. J Biol Chem 1995;270:13589-92.
27. Oh Y, Mullers HL, Ng L, Rosenfeld RG. Demonstration of receptors for insulin-like growth factor binding protein-3 on Hs578T human breast cancer cells. J Biol Chem 1993;268:26045-8.
28. Holly JMP. The physiological role of IGFBP-1. Acta Endocrinol 1991;124:55-62.
29. Binoux M, Hossenlopp P. Insulin-like growth and IGF binding proteins; comparison of human serum and lymph. J Clin Endocrinol Metab 1988;67:509-14.
30. Carlsson-Skwirut C, Lake M, Hartmanis M, Hall K, Sara VR. A comparison of the biological activity of the recombinant intact and truncated insulin-like growth factor 1 (IGF-1). Biochem Biophys Acta 1989;1011:192-7.
31. Elgin RG, Busby WH Jr, Clemmons DR. An insulin-like growth factor binding protein enhances the biologic response to IGF-1. Proc Natl Acad Sci USA 1987;84:3254-8.